Resolution of life- and limb-threatening pyoderma gangrenosum with spesolimab. [PDF]
Jonnalagadda A +5 more
europepmc +1 more source
Skin Basal Cell Carcinosarcoma in a Trichoblastic Guise-Molecular Characterization of a Novel Entity Mimicking a Pyoderma Gangrenosum. [PDF]
Georg P +4 more
europepmc +1 more source
Recurrence after healing in pyoderma gangrenosum: a prospective registry-based cohort study. [PDF]
Gillespie J +4 more
europepmc +1 more source
Bimekizumab for recalcitrant pyoderma gangrenosum. [PDF]
Tolete C +3 more
europepmc +1 more source
Successful Treatment of Recalcitrant Pyoderma Gangrenosum with Baricitinib in Two Patients with Rheumatoid Arthritis. [PDF]
Ciolfi C +5 more
europepmc +1 more source
Progressive Facial Ulcer: A Case Report of Pyoderma gangrenosum
Xian-Qi Zhang,* Zhen-Wei Tang,* Jing Jing Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People’s Republic of China*These authors contributed equally to this workCorrespondence:
Jing J, Zhang XQ, Tang ZW
core
Case Study of Fulminant Pyoderma Gangrenosum: Conservative Therapy-Cornerstone of Management. [PDF]
Yuen JC, Schneck JW, Shalin SC.
europepmc +1 more source
Infliximab-induced Remission of Postoperative Pyoderma Gangrenosum: A Case Report and Literature Review. [PDF]
Pratanrit P +4 more
europepmc +1 more source
Neutrophilic Dermatosis and Pyoderma Gangrenosum: A Not-So-Sweet Adverse Reaction to Pembrolizumab. [PDF]
Yang A, Tan B, Murrell DF.
europepmc +1 more source
Pyoderma Gangrenosum-Like Ulcer Secondary to Antiphospholipid Syndrome. [PDF]
Mijovic F +3 more
europepmc +1 more source

